microRNA-143 is associated with the survival of ALDH1⁺CD133⁺ osteosarcoma cells and the chemoresistance of osteosarcoma

Abstract

This study investigated the role of miR-143 in the chemoresistance of osteosarcoma tumor cells and the associated mechanisms. Real-time PCR was used to measure miR-143 levels. Western blot was used to detect protein expression. Cell proliferation was analyzed by MTT assay and Matrigel colony formation assay. Forced miR-143 expression was established by adenoviral vector infection. Cell death was detected by Hoechst33342 staining. Loss of miR-143 expression was observed in osteosarcomas, which correlated with shorter survival of patients with osteosarcomas underlying chemotherapy. In chemoresistant SAOS-2 and U2OS osteosarcomas cells, miR-143 levels were significantly downregulated and accompanied by increases in ATG2B, Bcl-2, and/or LC3-II protein levels, high rate of ALDH1 miR-143 may play a crucial role in the chemoresistance of osterosarcoma tumors.

RETRACTED ARTICLE: MicroRNA-23a enhances migration and invasion through PTEN in osteosarcoma

“…1 The proliferation and invasion of tumor cells are considered as the foundation of cancer survival and development. Accumulating evidences demonstrated that the induction of epithelial-mesenchymal transition (EMT) and aberrant expression of microRNAs (miRNAs) are associated with tumorigenesis, tumor progression, metastasis and relapse in cancers.…”

Anticancer effects of 10-hydroxycamptothecin induce apoptosis of human osteosarcoma through activating caspase-3, p53 and cytochrome�c pathways

“…Apoptosis, also termed programmed cell death, serves an important function in maintaining the normal physiological equilibrium of the human body and the elimination of old cells (24). Apoptosis is a process by which a gene actively determines the automatic life termination of a cell.…”

Effect of PI3K-mediated autophagy in human osteosarcoma MG63 cells on sensitivity to chemotherapy with cisplatin

“…With high malignant degree and poorer prognosis, osteosarcoma seriously influences the prognostic survival of patients. Although the present classical surgery combined with neoadjuvant chemotherapy can significantly improve patient's life quality and raise the survival rate, the relapse, metastasis and multi-drug resistance to chemotherapy heavily threaten the long-term survival rate of patients [2][3][4] . Therefore, it is very important to enhance the sensitivity of osteosarcoma to chemotherapy and study its molecular mechanism during the process of clinical treatment.…”